• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声触发和磁靶向纳米泡系统的构建及其用于双载药

Development of Ultrasound-Triggered and Magnetic-Targeted Nanobubble System for Dual-Drug Delivery.

机构信息

Biochemistry Department, Ege University Faculty of Science, Izmir, Turkey; Ege University Center for Drug Research, Development and Pharmacokinetic Applications, Izmir, Turkey.

Biochemistry Department, Ege University Faculty of Science, Izmir, Turkey; Ege University Center for Drug Research, Development and Pharmacokinetic Applications, Izmir, Turkey.

出版信息

J Pharm Sci. 2019 Mar;108(3):1272-1283. doi: 10.1016/j.xphs.2018.10.030. Epub 2018 Oct 26.

DOI:10.1016/j.xphs.2018.10.030
PMID:30773203
Abstract

Non-small cell lung cancer (NSCLC) constitutes more than 85% of lung cancer case. Pemetrexed is used to treat types of NSCLC, and pazopanib is used for some types of soft tissue sarcoma. The aim of the study was development of pemetrexed and pazopanib carrying nanobubble system with magnetic responsiveness and ultrasound sensitivity properties for targeted NSCLC therapy. Drugs were linked to newly designed peptide, and peptide drug conjugates were attached to amine-modified magnetite. Resulting nanoparticles were encapsulated into liposomes, and liposomes were extruded, then nanobubble system was prepared. Moreover, nanobubble biodistribution was monitored by in vivo imaging system. As a result, based on high-performance liquid chromatography data, magnetite and peptide-pemetrexed were conjugated with 54.02% yield, and magnetite and peptide-pazopanib were bound with 63.53% yield. Hydrodynamic size of nanobubbles, prepared from liposomes filtered through 800 nm and 400 nm, was determined as 491.1 ± 130.2 and 275.8 ± 117.8 nm, respectively. Carrier system was accumulated into tumor area with 80.22% yield of the injected carrier system. It was found that nanobubbles were magnetic responsive for accumulation via magnetic field and could be disrupted by ultrasound via focused acoustic pressure, which lead to targeted drug delivery. These nanobubble systems could be investigated for intravenous and inhaler administration in further studies.

摘要

非小细胞肺癌(NSCLC)占肺癌病例的 85%以上。培美曲塞用于治疗某些类型的非小细胞肺癌,帕唑帕尼用于治疗某些类型的软组织肉瘤。本研究的目的是开发具有磁响应性和超声敏感性的培美曲塞和帕唑帕尼纳米气泡系统,用于靶向治疗非小细胞肺癌。将药物与新设计的肽连接,将肽药物偶联物连接到胺修饰的磁铁矿上。得到的纳米颗粒被包封在脂质体中,然后将脂质体挤出,制备纳米气泡系统。此外,通过体内成像系统监测纳米气泡的生物分布。结果,根据高效液相色谱数据,磁铁矿和肽培美曲塞的偶联产率为 54.02%,磁铁矿和肽帕唑帕尼的偶联产率为 63.53%。通过 800nm 和 400nm 过滤的脂质体制备的纳米气泡的水动力学直径分别为 491.1±130.2nm 和 275.8±117.8nm。载体系统的肿瘤区累积率为注入载体系统的 80.22%。结果发现,纳米气泡具有通过磁场进行磁响应聚集的能力,并且可以通过聚焦声压破坏超声,从而实现靶向药物递送。这些纳米气泡系统可在进一步的研究中进行静脉内和吸入给药的研究。

相似文献

1
Development of Ultrasound-Triggered and Magnetic-Targeted Nanobubble System for Dual-Drug Delivery.超声触发和磁靶向纳米泡系统的构建及其用于双载药
J Pharm Sci. 2019 Mar;108(3):1272-1283. doi: 10.1016/j.xphs.2018.10.030. Epub 2018 Oct 26.
2
Delivery of pemetrexed by magnetic nanoparticles: design, characterization, and assessment.磁性纳米颗粒传递培美曲塞:设计、表征和评估。
Prep Biochem Biotechnol. 2020;50(3):215-225. doi: 10.1080/10826068.2019.1692220. Epub 2019 Nov 21.
3
Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.叶酸共轭两亲性聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒共递送顺铂和紫杉醇用于治疗非小细胞肺癌
Oncotarget. 2015 Dec 8;6(39):42150-68. doi: 10.18632/oncotarget.6243.
4
An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancer.帕唑帕尼联合培美曲塞一线治疗晚期非小细胞肺癌的开放标签、多中心、随机、II 期研究。
J Thorac Oncol. 2013 Dec;8(12):1529-37. doi: 10.1097/JTO.0000000000000005.
5
Importance of Bevacizumab Maintenance Following Combination Chemotherapy in Human Non-small Cell Lung Cancer Xenograft Models.贝伐单抗在人非小细胞肺癌异种移植模型联合化疗后维持治疗的重要性。
Anticancer Res. 2017 Feb;37(2):623-629. doi: 10.21873/anticanres.11356.
6
RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.载雷帕霉素修饰表阿霉素和地奥心血康的共载脂质体通过限制营养供应抑制非小细胞肺癌生长。
Cancer Sci. 2020 Feb;111(2):621-636. doi: 10.1111/cas.14256. Epub 2020 Jan 18.
7
RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.RGD 肽修饰的、紫杉醇前药为基础的、双药物负载的、氧化还原敏感的脂质-聚合物纳米粒用于增强肺癌治疗。
Biomed Pharmacother. 2018 Oct;106:275-284. doi: 10.1016/j.biopha.2018.06.137. Epub 2018 Jun 28.
8
Antitumor and antimetastatic effects of pemetrexed-loaded targeted nanoparticles in B bearing mice.载培美曲塞靶向纳米颗粒对荷瘤小鼠的抗肿瘤和抗转移作用
Drug Deliv. 2016 Sep;23(7):2566-2574. doi: 10.3109/10717544.2015.1033794. Epub 2015 May 22.
9
Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.使用多柔比星和姜黄素联合治疗肺癌:基于靶向前药、pH 敏感的纳米药物。
Biomed Pharmacother. 2019 Apr;112:108614. doi: 10.1016/j.biopha.2019.108614. Epub 2019 Feb 21.
10
Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells.通过超声介导的纳米气泡增强肺癌细胞中Survivin-siRNA的细胞摄取和基因沉默活性
Pharm Res. 2020 Aug 5;37(8):165. doi: 10.1007/s11095-020-02885-x.

引用本文的文献

1
Progress and potential of nanobubbles for ultrasound-mediated drug delivery.纳米气泡用于超声介导药物递送的进展与潜力
Expert Opin Drug Deliv. 2025 Jul;22(7):1007-1030. doi: 10.1080/17425247.2025.2505044. Epub 2025 May 18.
2
A Systematic Study on Long-acting Nanobubbles: Current Advancement and Prospects on Theranostic Properties.长效纳米气泡的系统研究:当前进展及诊疗特性展望
Adv Pharm Bull. 2024 Jul;14(2):278-301. doi: 10.34172/apb.2024.042. Epub 2024 Mar 17.
3
Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer.
测定载帕佐帕尼纳米粒的金属有机骨架包裹物对乳腺癌的抗肿瘤作用的 M2 巨噬细胞含量。
J Nanobiotechnology. 2024 Jul 20;22(1):429. doi: 10.1186/s12951-024-02694-z.
4
Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy.基于气泡的药物递送系统:从新一代诊断到治疗
J Funct Biomater. 2023 Jul 17;14(7):373. doi: 10.3390/jfb14070373.
5
Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy.基于脂质的蛋白酪氨酸激酶抑制剂递送纳米系统用于癌症治疗的见解。
Pharmaceutics. 2022 Dec 3;14(12):2706. doi: 10.3390/pharmaceutics14122706.
6
Recent advances in mechanical force-responsive drug delivery systems.机械力响应药物递送系统的最新进展。
Nanoscale Adv. 2022 Jul 18;4(17):3462-3478. doi: 10.1039/d2na00420h. eCollection 2022 Aug 23.
7
Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer.用于肺癌诊断和治疗的刺激响应型药物输送系统。
Molecules. 2022 Jan 30;27(3):948. doi: 10.3390/molecules27030948.
8
Targeted drug delivery strategies for precision medicines.精准药物的靶向给药策略。
Nat Rev Mater. 2021 Apr;6(4):351-370. doi: 10.1038/s41578-020-00269-6. Epub 2021 Feb 2.
9
Combined Ultrasound Treatment with Transferrin-Coupled Nanoparticles Improves Active Targeting of 4T1 Mammary Carcinoma Cells.联合转铁蛋白偶联纳米粒超声处理增强 4T1 乳腺癌细胞的主动靶向性。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211062325. doi: 10.1177/15330338211062325.
10
Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management.靶向表皮生长因子受体的纳米递送系统用于胶质瘤治疗
Pharmaceutics. 2020 Dec 10;12(12):1198. doi: 10.3390/pharmaceutics12121198.